Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity
More patients achieved RALI than traditional remission with similar or lower rates of radiographic progression as well as low rates of high-risk characteristics and adverse long-term outcomes. These results support RALI as a point-of-care clinical target to inform management.
Strong Clinical Evidence
Tested directly in patients through a prospective clinical trial or large multicenter human cohort.